Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer

Carlos A. Castaneda; Henry L. Gómez

doi:10.3816/CBC.2009.n.046

Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer

Carlos A. Castaneda, Henry L. Gómez

Medicina humana

Research output: Contribution to journal › Article › peer-review

Abstract

Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.

Original language	English
Pages (from-to)	E1-E3
Journal	Clinical Breast Cancer
Volume	9
Issue number	4
DOIs	https://doi.org/10.3816/CBC.2009.n.046
State	Published - 2009

Keywords

Beta-tubulin
Capecitabine
Ixabepilone
MDR1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3816/CBC.2009.n.046

Cite this

@article{c941031f81614f9097c025a795eb2833,

title = "Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer",

abstract = "Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.",

keywords = "Beta-tubulin, Capecitabine, Ixabepilone, MDR1",

author = "Castaneda, {Carlos A.} and G{\'o}mez, {Henry L.}",

year = "2009",

doi = "10.3816/CBC.2009.n.046",

language = "Ingl{\'e}s",

volume = "9",

pages = "E1--E3",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer

AU - Castaneda, Carlos A.

AU - Gómez, Henry L.

PY - 2009

Y1 - 2009

N2 - Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.

AB - Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.

KW - Beta-tubulin

KW - Capecitabine

KW - Ixabepilone

KW - MDR1

UR - http://www.scopus.com/inward/record.url?scp=73349098403&partnerID=8YFLogxK

U2 - 10.3816/CBC.2009.n.046

DO - 10.3816/CBC.2009.n.046

M3 - Artículo

AN - SCOPUS:73349098403

SN - 1526-8209

VL - 9

SP - E1-E3

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

IS - 4

ER -

Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this